Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Research at City of Hope reveals how common white button mushrooms might enhance prostate cancer treatment through surprising ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...